Dolutegravir Safety Review: WHO Subcommittee Meeting
→
Europe/Zurich
In-Person
E170 (WHO, Geneva, Switzerland)
E170
WHO
Avenue Appia 20, 1202, Geneva, Switzerland
Description
Meeting of the sub-committee of the WHO Advisory Committee on Safety of Medicinal Products (ACSoMP) on the signal of neural tube defect (NTD) with dolutegravir